PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer
Dana-Farber Cancer Institute
Erica L Mayer; Yue Ren; Nikhil Wagle; Reshma Mahtani; Cynthia Ma; Angela DeMichele; Massimo Cristofanilli; Jane Meisel; Kathy D Miller; Yara Abdou; Elizabeth C Riley; Rubina Qamar; Priyanka Sharma; Sonya Reid; Natalie Sinclair; Meredith Faggen; Caroline C Block; Naomi Ko; Ann H Partridge; Wendy Y Chen; Michelle DeMeo; Victoria Attaya; Amanda Okpoebo; Jillian Alberti; Yuan Liu; Eric Gauthier; Harold J Burstein; Meredith M Regan; Sara M Tolaney